Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, GA

Clinical Trial Details

Overview

Research Study Summary

Tardive Dyskinesia in Schizophrenic Patients

Purpose

NeuroTrials Research is conducting a study to determine the effectiveness of an investigational drug on the involuntary repetitive body movements known as tardive dyskinesia in individuals with schizophrenia or schizoaffective disorder. Qualified participants receive all study-related care and study drug at no cost, and compensation is available for time and travel.

Call (404) 851-9934 or visit www.neurotrials.com

Patient Inclusion Criteria:

  • You may qualify if you:
    • are 18-65
    • have a diagnosis of schizophrenia or schizoaffective disorder
    • have a diagnosis of tardive dyskinesia
    • are otherwise in good health

Patient Exclusion Criteria:

  • See inclusions.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

NeuroTrials Research, Inc.
1100 Johnson Ferry Road, Suite 420
Atlanta, GA 30342
Phone: 404-851-9934

View Map

Research Center Information: NeuroTrials Research, Inc.

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 183396

Date Last Changed: July 16, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.